US Market Report for Sleep Diagnostic Devices 2017 – MedCore

US Market Report for Sleep Diagnostic Devices 2017 – MedCore

0

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 7/1/2017
  • Pages: 235
  • Type: MedCore

The total market for sleep apnea diagnostic devices consists of four types of devices: type I (full attended PSG), type II (portable unattended PSG), type III (HST with a minimum of four channels) and type IV (HST with a minimum of three channels). The longest standing test type, the “golden standard” has been
type I tests which are conducted in a hospital or lab setting and require attendance of a lab technician or doctor. In terms of overall market total for the market for sleep diagnostic tests, type I devices represented approximately 63% of the market in 2016. In terms of sheer procedure volume, these devices are still used the most in the market; however, this is set to shift in the near future.

General Report Contents
– Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
– Market Drivers & Limiters for each chapter segment
– Competitive Analysis for each chapter segment
– Section on recent mergers & acquisitions
Obstructive sleep apnea is a respiratory disorder wherein an individual’s airway is obstructed during sleep as muscles relax and the airway walls and tissue collapse. The resulting asphyxia arouses the individual from the deeper stages of sleep so that normal breathing can be restored. It is this disruption of regular sleep rhythms that causes the negative symptoms associated with sleep apnea. During an apneic event, breathing ceases long enough to allow several normal breaths to be missed, and these disruptions continue throughout the sleep session. In order to be considered an apneic event, a ten second interval between breaths and neurological arousal and/or blood oxygen desaturation are required.
There are three classifications of sleep apnea: obstructive, central and complex. The first, obstructive, is the most common (approximately 80% of cases) and is the focus of this chapter. Obstructive sleep apnea (OSA) is defined as an interruption in breathing despite respiratory effort from the patient. The patient’s nervous system stimulates the muscles involved in breathing, but a physical obstruction in the airway prevents the airway from opening. In the much less prevalent central sleep apnea, observed in only 0.4% of total cases, breathing is interrupted by a physiological lack of respiratory effort caused by the central nervous system. The final type of sleep apnea is complex, where the patient experiences central and obstructive sleep apnea features transiently through the sleep period. Complex apnea comprises approximately 15% of cases. Because of the nature of sleep apnea, individuals that are affected by the condition are rarely aware of their difficulties breathing while asleep, and symptoms may be present for decades before the sufferer is diagnosed and subsequently treated. It is estimated that only 15% of patients in the U.S. who have sleep apnea have been diagnosed.
OSA is the most prevalent form of sleep-disordered breathing. Due to relaxation of the muscles during sleep, the walls of soft tissue in the throat have a propensity to collapse. It is important to treat severe, chronic OSA due to the risks associated with sleep deprivation (including dangerous driving), low blood oxygen and more serious complications, including a form of congestive heart failure called corpulmonale.
Sleep apnea diagnostic devices are segmented into four different categories.



The "US Market Report Suite for Anesthesia, Respiratory and Sleep Management Devices 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Philips Respironics
ResMed
CAIRE Inc.
Becton Dickinson
GE Healthcare
Covidien
DeVilbiss
Invacare
Dr?ger
Teleflex
Fisher & Paykel
Inogen
Smiths Medical
Ambu
Mindray
Omron
Maquet
Westmed
Natus Medical
Others include: Airgas, BD-CareFusion, Cramer Decker, eVent, Flexicare, Flotec, Fukuda Denshi, GE Healthcare, Global Medical Holdings, Graham Field, Intersurgical, Invacare, Mada Medical, Maquet, Massimo, Medis, Mercury Medical, Metal Impact, Nellcor, Nidek, O2 Concepts, Oxlife, Penlon, Percussionaire, Philips Respironics, Sechrist, Somnostar, Spacelabs, SunMed, Teleflex, Ventlab, VisionAire, Welch Allyn, Zoll, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Sign Up

Already have an account? Sign in

×